Group 1 - China Uranium Industry (001280) will open for subscription on November 21, becoming the first uranium stock in A-shares, focusing on natural uranium resource mining, sales, and trade [1] - The company also engages in the comprehensive utilization and sales of radioactive co-associated mineral resources such as monazite and uranium molybdenum [1] Group 2 - Vice Premier He Lifeng emphasized the need to continuously improve foreign trade quality and efficiency during his research in Hubei and Hunan, aiming to support high-quality development of the manufacturing industry [2] - He noted that despite a challenging external environment, China's foreign trade has maintained stable growth, providing strong support for domestic economic development [2] Group 3 - The Ministry of Commerce stated that China is strictly implementing the consensus reached during the China-US Kuala Lumpur economic and trade consultations [3] Group 4 - Minister of Commerce Wang Wentao held a video meeting with UK Trade Secretary Peter Kyle to discuss the ASML semiconductor issue, emphasizing that the responsibility lies with the Netherlands [4] - Wang indicated that the Netherlands' recent suspension of an administrative order is a positive step towards resolving the semiconductor supply chain crisis [4] Group 5 - The Ministry of Foreign Affairs reiterated that Japanese seafood products currently have no market in China due to public sentiment against Japan's leadership statements on significant issues [5] Group 6 - The China Securities Regulatory Commission (CSRC) highlighted the need to enhance the inclusiveness and adaptability of capital market systems to promote high-quality development [6] Group 7 - Guangdong Province is focusing on developing cutting-edge technology, particularly in areas of strategic importance and "bottleneck" technologies [8] - The provincial government aims to leverage the strengths of major cities like Guangzhou and Shenzhen to drive technological innovation [8] Group 8 - Guangdong's government has launched initiatives to promote innovation in artificial intelligence and robotics, including the "AI+" and "Robot+" actions [9] - The province plans to expand the development of consumer-level smart terminal products and enhance the integration of online and offline business models [9] Group 9 - The Chinese Academy of Sciences signed a new cooperation agreement with the Shanghai Municipal Government to accelerate the construction of an international science and technology innovation center [10] - The agreement aims to enhance Shanghai's role as a global technology innovation hub [10] Group 10 - The Ministry of Commerce announced a new policy to guide local governments in promoting the export of used cars, shifting focus from "scale growth" to "value growth" [11] - The policy aims to improve the overall development level and international competitiveness of the used car export industry [11] Group 11 - The Guangzhou Futures Exchange announced adjustments to trading fees and limits for lithium carbonate futures contracts, effective November 24, 2025 [12] - New trading fee standards and daily opening limits for various contracts have been established to regulate market activity [12] Group 12 - The 18th China-EU Investment Trade and Technology Cooperation Fair opened in Chengdu, with EU representatives expressing optimism about future cooperation with Chinese enterprises [13] - The event highlighted the potential for collaboration in emerging sectors such as artificial intelligence and robotics [14]

Group 1: Pharmaceutical Developments - Fosun Pharma's subsidiary has received breakthrough therapy designation for its PD-1 monoclonal antibody, Surulintinib, for gastric cancer treatment, marking a significant milestone as no other PD-1 targeted monoclonal antibody has been approved for this indication globally [1] - Surulintinib is already approved in China, the EU, and the UK for various cancers, including non-small cell lung cancer and esophageal squamous cell carcinoma [1] Group 2: Supply Agreements - EVE Energy has signed a procurement framework agreement with Simor International for battery cell supplies from 2026 to 2028, although the agreement does not specify financial amounts [1] - The actual financial impact will depend on future orders and will not significantly affect the company's performance in 2025 [1] Group 3: Corporate Actions - Huarong Chemical has not yet introduced clients in the photolithography or photolithography machine sectors, focusing instead on potassium hydroxide and chlorine products for semiconductor and photovoltaic applications [2] - Xunji Technology plans to transfer certain PCB manufacturing assets to its wholly-owned subsidiary and will inject 49.9 million yuan into the subsidiary to support its operations [3] - TuoJing Technology's major shareholder plans to reduce its stake by up to 3% through block trading, with a reduction period set from December 2025 to March 2026 [4] Group 4: Market Activities - Moer Thread has announced a public offering of 70 million shares at a price of 114.28 yuan per share, aiming to raise approximately 8 billion yuan, with a net amount expected to be around 7.576 billion yuan after expenses [5] - Hefu China has experienced a significant stock price increase, with a cumulative rise of 291.92% over a short period, leading to potential market volatility and a possible request for trading suspension [6]

格隆汇11月20日丨荃银高科(300087.SZ)公布，收到公司控股股东中国种子集团有限公司（简称"中种集 团"）与其一致行动人贾桂兰女士、王玉林先生的通知，其三方协商一致签署了《表决权委托及一致行 动协议终止协议》，贾桂兰女士、王玉林先生退出与公司控股股东中种集团的一致行动关系。本次一致 行动关系解除后，贾桂兰女士、王玉林先生不再是公司控股股东中国种子集团有限公司的一致行动人， 公司控股股东中国种子集团有限公司合计控制公司20.51%股份对应的表决权。 ...

格隆汇11月20日丨荃银高科(300087.SZ)公布，收到公司控股股东中国种子集团有限公司（简称"中种集 团"）与其一致行动人贾桂兰女士、王玉林先生的通知，其三方协商一致签署了《表决权委托及一致行 动协议终止协议》，贾桂兰女士、王玉林先生退出与公司控股股东中种集团的一致行动关系。本次一致 行动关系解除后，贾桂兰女士、王玉林先生不再是公司控股股东中国种子集团有限公司的一致行动人， 公司控股股东中国种子集团有限公司合计控制公司20.51%股份对应的表决权。 ...

Resumption of Trading - Strait Innovation's stock trading suspension has been completed, and it will resume trading on November 21, 2025 [1] Mergers and Acquisitions - Qianying High-Tech: Zhongzhong Group plans to make a tender offer to acquire 20% of shares at a price of 11.85 yuan per share [2] - Dongfang Yuhong: A wholly-owned subsidiary intends to acquire 60% equity of Brazil's Novakem for 144 million yuan, expanding into the Latin American market [3] Share Buybacks and Increases - Aidi Precision plans to repurchase shares worth 100 million to 200 million yuan, with a repurchase price not exceeding 27 yuan per share [4] - Hangcai Co. plans to repurchase shares worth 50 million to 100 million yuan, with a repurchase price not exceeding 80 yuan per share [5] - Feiwo Technology's controlling shareholder plans to increase holdings of the company's shares by 40 million to 70 million yuan [6] External Investments and Daily Operations - Yiwei Lithium Energy has signed a procurement framework agreement for battery cells with Smoore International for the years 2026-2028 [7] - Nanfeng Co. received a bid notification from China General Nuclear Power Engineering, with bid amounts of 45.7 million yuan and 47.17 million yuan [8] - Fosun Pharma's subsidiary has had a drug included in the breakthrough therapy designation program, marking the first monoclonal antibody targeting PD-1 approved for gastric cancer neoadjuvant/adjuvant therapy globally [8] - Longhua New Materials has completed the construction and production of a project with an annual capacity of 330,000 tons of polyether polyol [8] - Lek Electric plans to transfer 90% equity of its wholly-owned subsidiary Precision Machinery for 235 million yuan [9] - Yingboer has officially become a supplier for VOLOCOPTER, providing development services for the electric propulsion system of the XPro aircraft [10] - Shandong Steel's controlling subsidiary plans to apply for bankruptcy liquidation, expecting an increase in profit of 15.88 million yuan [11] - Zhouming Technology has established a controlling subsidiary, Zhixian Robotics [12] - Huakang Clean has pre-qualified for the purification system project at Keqiao Future Medical Center, with a bid price of 176 million yuan [13] - China Nuclear Construction has achieved new contracts totaling 123.84 billion yuan as of October [13]

荃银高科公告，公司于2025年11月20日收到中国种子集团有限公司就本次要约收购事宜出具的《安徽荃 银高科种业股份有限公司要约收购报告书摘要》。本次要约收购的收购人为中种集团，预定要约收购股 份数量为1.89亿股，约占荃银高科已发行股份总数的20.00%，要约收购价格为11.85元/股。 ...

关于 《安徽荃银高科种业股份有限公司要约收购报告书摘要》 之 专项财务顾问意见 致：中国种子集团有限公司 中国国际金融股份有限公司 中国国际金融股份有限公司作为本次中国种子集团有限公司（以下简称"收 购人"）要约收购安徽荃银高科种业股份有限公司（以下简称"荃银高科"）股份 的财务顾问，已对收购人为本次要约收购编制的《安徽荃银高科种业股份有限公 司要约收购报告书摘要》（以下简称"要约收购报告书摘要"）及相关事项进行了 核查，并出具以下专项财务顾问意见： 本财务顾问认为，截至要约收购报告书摘要签署之日，收购人本次要约收购 符合《中华人民共和国证券法》《上市公司收购管理办法》等法律法规的规定， 收购人具备收购荃银高科股份的主体资格，不存在《上市公司收购管理办法》第 六条规定的情形及法律法规禁止收购上市公司的情形，收购人具备实际履行本次 要约收购的能力。 本财务顾问同意收购人在要约收购报告书摘要中引用上述专项财务顾问意 见。 （本页无正文，为《中国国际金融股份有限公司关于<安徽荃银高科种业股 份有限公司要约收购报告书摘要>之专项财务顾问意见》签章页） 中国国际金融股份有限公司 年 月 日 ...

安徽荃银高科种业股份有限公司 要约收购报告书摘要 上市公司名称：安徽荃银高科种业股份有限公司 股票上市地点：深圳证券交易所创业板 股票简称：荃银高科 股票代码：300087 收购人名称：中国种子集团有限公司 收购人住所：海南省三亚市崖州区还金路金茂南繁科创中心 A 座 8 楼 001 号 通讯地址：海南省三亚市崖州区还金路金茂南繁科创中心 A 座 8 楼 001 号 收购人财务顾问 签署日期：二〇二五年十一月 重要声明 本要约收购报告书摘要的目的仅为向社会公众投资者提供本次要约收购的 简要情况，投资者在做出是否预受要约的决定之前，应当仔细阅读要约收购报告 书全文，并以此作为投资决定的依据。要约收购报告书全文将刊登于深圳证券交 易所网站（http://www.szse.cn）。 本次收购要约尚未生效，具有相当的不确定性。要约收购报告书全文将在收 购人正式发出要约收购之日起刊登于深圳证券交易所网站 （http://www.szse.com.cn）。 2 安徽荃银高科种业股份有限公司要约收购报告书摘要 特别提示 本部分所述的词语或简称与本报告书摘要"释义"部分所定义的词语或简称 具有相同的涵义。 1、本次要约收购的 ...

安徽荃银高科种业股份有限公司 简式权益变动报告书 上市公司名称：安徽荃银高科种业股份有限公司 股票上市地点：深圳证券交易所创业板 股票简称：荃银高科 股票代码：300087 信息披露义务人名称：中国种子集团有限公司 住所：海南省三亚市崖州区还金路金茂南繁科创中心 A 座 8 楼 001 号 通讯地址：海南省三亚市崖州区还金路金茂南繁科创中心 A 座 8 楼 001 号 股份变动性质：解除一致行动关系，不涉及信息披露义务人持股数量的增减 签署日期：2025 年 11 月 20 日 安徽荃银高科种业股份有限公司简式权益变动报告书 信息披露义务人声明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 一、本报告书系信息披露义务人依据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司收购管理办法》《公开发行证券的公司信息披露内容与格式 准则第 15 号——权益变动报告书》及其他相关的法律、法规和规范性文件编制。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反 信息披露义务人内部规则中的任何条款，或与之相冲突 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《公 ...

安徽荃银高科种业股份有限公司 简式权益变动报告书 上市公司名称：安徽荃银高科种业股份有限公司 股票上市地点：深圳证券交易所创业板 股票简称：荃银高科 股票代码：300087 信息披露义务人（一）：贾桂兰 住所：合肥市政务区****** 通讯地址：合肥市政务区****** 信息披露义务人（二）：王玉林 住所：合肥市政务区****** 通讯地址：合肥市政务区****** 股份变动性质：解除一致行动关系，不涉及信息披露义务人持股数量的增减 签署日期：2025 年 11 月 20 日 安徽荃银高科种业股份有限公司简式权益变动报告书 信息披露义务人声明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 一、本报告书系信息披露义务人依据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司收购管理办法》《公开发行证券的公司信息披露内容与格式 准则第 15 号——权益变动报告书》及其他相关的法律、法规和规范性文件编制。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反 信息披露义务人内部规则中的任何条款，或与之相冲突 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《公开 ...